Comparison of the chromosomal pattern of primary testicular nonseminomas and residual mature teratomas after chemotherapy.
About 70 to 75% of patients with nonseminomatous testicular germ cell tumors (NSs) present with metastases. When these metastases are treated with chemotherapy, often residual mature teratoma (RMT) is left. RMT is composed of fully differentiated somatic tissue. Untreated metastases of NSs rarely consist exclusively of mature somatic tissue. Apparently, after chemotherapy treatment there is a shift towards higher degrees of differentiation. Investigating tumor progression and the mechanism(s) involved in therapy-related differentiation, we compared the cytogenetically abnormal karyotypes of a series of 70 NSs with those of 31 RMTs. In NSs and RMTs, the modal total chromosome number does not differ and is in the triploid range. Both the frequency and the average copy number of i(12p) are the same, and the pattern of chromosomal over- and underrepresentation and distribution of breakpoints do not differ significantly in these series. So, we found the chromosomal pattern of RMTs as abnormal as those of primary NSs. Based on cytogenetics, we found no indication that specific chromosomal alterations parallel metastasis and therapy-related differentiation of the metastases. The cytogenetic data suggest that both induction of differentiation of (selected) cells or selection of cells with capacity to differentiate are possible mechanisms for the therapy-related differentiation of RMTs.
van Echten
J
J
Department of Medical Genetics, University of Groningen, The Netherlands.
van der Vloedt
W S
WS
van de Pol
M
M
Dam
A
A
te Meerman
G J
GJ
Schraffordt Koops
H
H
Sleijfer
D T
DT
Oosterhuis
J W
JW
de Jong
B
B
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002877:Chromosomes, Human; D018237:Germinoma / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D007621:Karyotyping; D008297:Male; D018365:Neoplasm, Residual; D013724:Teratoma / Q000188:drug therapy / Q000235:genetics*; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000556:secondary
D000970:Antineoplastic Agents